Literature DB >> 16403063

Relationship between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome.

Hiroshi Furushima1, Masaomi Chinushi, Takashi Hirono, Hirotaka Sugiura, Hiroshi Watanabe, Satoru Komura, Takashi Washizuka, Yoshifusa Aizawa.   

Abstract

BACKGROUND: Electrical abnormalities in the RVOT may be involved in Brugada syndrome.
OBJECTIVES: We investigated the relationship between the signal-averaged ECG (SAECG) and electrophysiologic study (EPS), especially focusing on conduction delay in the outflow tract of the right ventricle (RVOT) and its contribution to clinical characteristics.
METHODS: Twenty-four patients with Brugada syndrome (23 men and 1 woman; 61 +/- 16 years old) were studied. We assessed the presence of late potential (LP) in SAECG and the filtered QRS duration in the right precordial leads (V1 or V2; RfQRS) and in the left precordial leads (V5 or V6; LfQRS) and the difference between them. In 18 patients, SAECG was evaluated for an LP on three separate occasions.
RESULTS: SAECG was positive for LP in 15 patients at least once; and in 7 patients, SAECG was positive for an LP on multiple occasions, and 6 of 7 patients (86%) had a history of cardiac arrest. The difference between RfQRS and LfQRS was significantly greater in patients with cardiac arrest than in patients with syncope or in asymptomatic patients; 29 +/- 10, 14 +/- 11 (P < 0.01), and 7 +/- 5 msec (P < 0.001), respectively. All patients were alive and one patient with cardiac arrest had an appropriate VF therapy delivered by the ICD.
CONCLUSIONS: The dominant prolongation of the filtered QRS duration in the right precordial leads may be related to the risk of arrhythmic event in Brugada syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 16403063     DOI: 10.1111/j.1540-8167.2005.00262.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

1.  Sodium channel blockers enhance the temporal QT interval variability in the right precordial leads in Brugada syndrome.

Authors:  Tetsuzou Kanemori; Hiroki Shimizu; Katsumi Oka; Yoshio Furukawa; Kenji Hiromoto; Takanao Mine; Tohru Masuyama; Mitsumasa Ohyanagi
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-01       Impact factor: 1.468

Review 2.  The Brugada Syndrome - Diagnosis, Clinical Implications and Risk Stratification.

Authors:  Velislav N Batchvarov
Journal:  Eur Cardiol       Date:  2014-12

Review 3.  Brugada Syndrome:Risk Stratification And Management.

Authors:  Yoshifusa Aizawa
Journal:  J Atr Fibrillation       Date:  2016-10-31

4.  Wide QRS complex and the risk of major arrhythmic events in Brugada syndrome patients: A systematic review and meta-analysis.

Authors:  Pattara Rattanawong; Jakrin Kewcharoen; Chol Techorueangwiwat; Chanavuth Kanitsoraphan; Raktham Mekritthikrai; Narut Prasitlumkum; Prapaipan Puttapiban; Poemlarp Mekraksakit; Wasawat Vutthikraivit; Dan Sorajja
Journal:  J Arrhythm       Date:  2019-12-27

Review 5.  Electrocardiographic methods for diagnosis and risk stratification in the Brugada syndrome.

Authors:  Abdulrahman Naseef; Elijah R Behr; Velislav N Batchvarov
Journal:  J Saudi Heart Assoc       Date:  2014-07-03

6.  Clinical outcome of patients with the Brugada type 1 electrocardiogram without prophylactic implantable cardioverter defibrillator in primary prevention: a cumulative analysis of seven large prospective studies.

Authors:  Pietro Delise; Vincent Probst; Giuseppe Allocca; Nadir Sitta; Luigi Sciarra; Josep Brugada; Shiro Kamakura; Masahiko Takagi; Carla Giustetto; Leonardo Calo
Journal:  Europace       Date:  2018-06-01       Impact factor: 5.214

7.  Gender Differences in Prognosis and Risk Stratification of Brugada Syndrome: A Pooled Analysis of 4,140 Patients From 24 Clinical Trials.

Authors:  Mengchen Yuan; Chao Tian; Xinye Li; Xinyu Yang; Xiaofeng Wang; Yihan Yang; Nian Liu; Kengo F Kusano; Hector Barajas-Martinez; Dan Hu; Hongcai Shang; Yonghong Gao; Yanwei Xing
Journal:  Front Physiol       Date:  2018-08-22       Impact factor: 4.566

Review 8.  Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.

Authors:  Jakub Sroubek; Vincent Probst; Andrea Mazzanti; Pietro Delise; Jesus Castro Hevia; Kimie Ohkubo; Alessandro Zorzi; Jean Champagne; Anna Kostopoulou; Xiaoyan Yin; Carlo Napolitano; David J Milan; Arthur Wilde; Frederic Sacher; Martin Borggrefe; Patrick T Ellinor; George Theodorakis; Isabelle Nault; Domenico Corrado; Ichiro Watanabe; Charles Antzelevitch; Giuseppe Allocca; Silvia G Priori; Steven A Lubitz
Journal:  Circulation       Date:  2016-01-21       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.